339 related articles for article (PubMed ID: 12656747)
21. Absence of alternative splicing in bcr-abl mRNA in chronic myeloid leukemia cell lines.
Hermans A; Selleri L; Gow J; Grosveld GC
Blood; 1988 Dec; 72(6):2066-9. PubMed ID: 2848601
[TBL] [Abstract][Full Text] [Related]
22. The role of Bcr-Abl in chronic myeloid leukemia and stem cell biology.
Witte O
Semin Hematol; 2001 Jul; 38(3 Suppl 8):3-8. PubMed ID: 11526595
[TBL] [Abstract][Full Text] [Related]
23. Leukemia cells fall on their swords.
Rutherford A
Trends Mol Med; 2001 Apr; 7(4):149. PubMed ID: 11286930
[No Abstract] [Full Text] [Related]
24. Fluorescent in-situ hybridization (FISH) for BCR/ABL in chronic myeloid leukemia after bone marrow transplantation.
Chauffaille Mde L; Oliveira JS; Romeo M; Kerbauy J
Sao Paulo Med J; 2001 Jan; 119(1):16-8. PubMed ID: 11175620
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies.
Warmuth M; Danhauser-Riedl S; Hallek M
Ann Hematol; 1999 Feb; 78(2):49-64. PubMed ID: 10089019
[TBL] [Abstract][Full Text] [Related]
26. The first case of six-way complex translocation of t(4;7;9;22;8;14) in a patient with chronic myeloid leukemia.
Bi X; Li C; Shang M; Han B; Li H; Sun L; Lin Y; Yang S
J Hematop; 2024 Jun; 17(2):97-101. PubMed ID: 38492169
[TBL] [Abstract][Full Text] [Related]
27. Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML.
Honda H; Ushijima T; Wakazono K; Oda H; Tanaka Y; Aizawa Si; Ishikawa T; Yazaki Y; Hirai H
Blood; 2000 Feb; 95(4):1144-50. PubMed ID: 10666183
[TBL] [Abstract][Full Text] [Related]
28. A unique, complex variant philadelphia chromosome translocation in a patient with typical chronic myelogenous leukemia.
Oudat R; Khan Z; Glassman AB
Arch Pathol Lab Med; 2001 Mar; 125(3):437-9. PubMed ID: 11231500
[TBL] [Abstract][Full Text] [Related]
29. Use of alpha-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation.
Higano CS; Chielens D; Raskind W; Bryant E; Flowers ME; Radich J; Clift R; Appelbaum F
Blood; 1997 Oct; 90(7):2549-54. PubMed ID: 9326220
[TBL] [Abstract][Full Text] [Related]
30. Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial.
Jain N; Reuben JM; Kantarjian H; Li C; Gao H; Lee BN; Cohen EN; Ebarb T; Scheinberg DA; Cortes J
Cancer; 2009 Sep; 115(17):3924-34. PubMed ID: 19536894
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107.
Wetzler M; Donohue KA; Odenike OM; Feldman EJ; Hurd DD; Stone RM; Westerfelt P; Bloomfield CD; Larson RA
Leuk Lymphoma; 2008 Jul; 49(7):1274-8. PubMed ID: 18452072
[TBL] [Abstract][Full Text] [Related]
32. Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies.
Bose P; Perkins EB; Honeycut C; Wellons MD; Stefan T; Jacobberger JW; Kontopodis E; Beumer JH; Egorin MJ; Imamura CK; Douglas Figg W; Karp JE; Koc ON; Cooper BW; Luger SM; Colevas AD; Roberts JD; Grant S
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1657-67. PubMed ID: 22349810
[TBL] [Abstract][Full Text] [Related]
33. Detection of the molecular abnormality in chronic myeloid leukemia by use of the polymerase chain reaction.
Dobrovic A; Trainor KJ; Morley AA
Blood; 1988 Dec; 72(6):2063-5. PubMed ID: 3143430
[TBL] [Abstract][Full Text] [Related]
34. Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification.
le Coutre P; Tassi E; Varella-Garcia M; Barni R; Mologni L; Cabrita G; Marchesi E; Supino R; Gambacorti-Passerini C
Blood; 2000 Mar; 95(5):1758-66. PubMed ID: 10688835
[TBL] [Abstract][Full Text] [Related]
35. BCR/ABL mRNA and the P210(BCR/ABL) protein are downmodulated by interferon-alpha in chronic myeloid leukemia patients.
Pane F; Mostarda I; Selleri C; Salzano R; Raiola AM; Luciano L; Saglio G; Rotoli B; Salvatore F
Blood; 1999 Oct; 94(7):2200-7. PubMed ID: 10498589
[TBL] [Abstract][Full Text] [Related]
36. ABL amplification in a patient with lymphoid blast crisis of chronic myelogenous leukaemia.
Kenner L; Beham-Schmid C; Kerbl R; Schmidt HH; Sill H; Hoefler G
Virchows Arch; 1999 Mar; 434(3):255-7. PubMed ID: 10190307
[TBL] [Abstract][Full Text] [Related]
37. Direct visualization of the transposed ABL gene in a duplicated masked Ph chromosome.
Macera MJ; Szabo P; Lin JH; DeSalvo AT; Shah HO; Verma RS
Genes Chromosomes Cancer; 1993 Oct; 8(2):127-30. PubMed ID: 7504516
[TBL] [Abstract][Full Text] [Related]
38. Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells.
Talpaz M; Kantarjian H; Liang J; Calvert L; Hamer J; Tibbits P; Durett A; Claxton D; Giralt S; Khouri I
Blood; 1995 Jun; 85(11):3257-63. PubMed ID: 7756658
[TBL] [Abstract][Full Text] [Related]
39. Extensive cytogenetic studies of clonality following interferon-alpha therapy in chronic myeloid leukemia occurring in monosomic cells in a patient with Turner syndrome mosaic.
Takeshita A; Shinjo K; Yamashita M; Fujisawa S; Naito K; Ohnishi K; Takahashi K; Matsui H; Ohno R
Leukemia; 1999 Nov; 13(11):1749-53. PubMed ID: 10557048
[TBL] [Abstract][Full Text] [Related]
40. A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL gene.
Polák J; Zemanová Z; Michalová K; Klamová H; Cermák J; Haskovec C
Leukemia; 1998 Feb; 12(2):250. PubMed ID: 9519792
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
